Gilead Subsidiary Wins Louisiana’s ‘Netflix’ Hep C Contract

Drug Industry Daily
A A
Gilead subsidiary Asegua Therapeutics won the exclusive contract to treat Louisiana’s poor and imprisoned hepatitis C patients, health officials in the Pelican State announced Tuesday.

To View This Article:

Login

Subscribe To Drug Industry Daily